Acumen Pharmaceuticals, Inc.
NASDAQABOS cost to borrow surges to 1.32% from 0.31% a week ago, up 316% in seven days.
Snapshot as of 1 Jul 2026
No long-form analysis yet for ABOS. Pulse alerts and the live data picture are available on ORTEX.
Open ABOS on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABOS — free to start on ORTEX.
Sign up for free →Open ABOS on ORTEX